rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
2	T-Cell Prolymphocytic Leukemia	C0023494	6	30	0.0	1.0193679918450562e-06	JAK3,IL2,IL2RA,JAK1,STAT5B,STAT5A
5	T-cell lymphoma	C0079772	11	302	0.0	2.5484199796126405e-06	JAK3,SOS1,IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,STAT5B,CSF2,IL3
8	Acute leukemia	C0085669	12	525	0.0	4.077471967380225e-06	JAK3,IL2RB,NRAS,IL2,JAK1,IL5,STAT5B,STAT5A,IL3RA,CSF2,INPP5D,IL3
22	Respiratory Syncytial Virus Infections	C0035235	10	299	5.24469356833e-13	1.1213047910295617e-05	IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,IL5RA,STAT5A,CSF2,IL3
24	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	10	348	5.78104231153e-12	1.2232415902140673e-05	JAK3,IL2RB,NRAS,IL2,IL2RA,IL2RG,IL5,STAT5B,STAT5A,IL3
26	Multiple Myeloma	C0026764	15	1236	8.31434920912e-12	1.325178389398573e-05	JAK3,GRB2,INPPL1,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,STAT5B,STAT5A,CSF2,INPP5D,IL3
27	Chronic myeloid leukemia	C0023473	14	822	9.79727410311e-12	1.3761467889908258e-05	JAK3,GRB2,INPPL1,SOS1,NRAS,IL2,IL2RA,IL5,IL5RA,STAT5B,STAT5A,CSF2,INPP5D,IL3
28	Leukemia, Large Granular Lymphocytic	C1522378	5	54	1.13119513756e-11	1.4271151885830786e-05	IL2RB,IL2,IL2RA,STAT5B,STAT5A
29	Myeloproliferative Disorders	C0027022	9	245	1.2038148256e-11	1.4780835881753314e-05	JAK3,IL2RB,NRAS,JAK1,STAT5B,STAT5A,CSF2,INPP5D,IL3
30	Lymphoproliferative disorder	C0024314	7	236	1.23663301821e-11	1.5290519877675842e-05	JAK3,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5
31	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	17	1913	1.27171606579e-11	1.580020387359837e-05	JAK3,GRB2,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL2RG,IL5,STAT5B,STAT5A,CSF2RB,IL3RA,CSF2,INPP5D,IL3
32	Juvenile myelomonocytic leukemia	C0349639	7	116	1.37773126241e-11	1.63098878695209e-05	JAK3,SOS1,NRAS,IL2RG,CSF2,INPP5D,IL3
33	Chorioamnionitis	C0008495	7	195	1.64066538133e-11	1.6819571865443423e-05	IL2,IL2RA,IL5,IL5RA,IL3RA,CSF2,IL3
34	Eosinophilia	C0014457	7	175	1.93827176531e-11	1.732925586136595e-05	IL2,IL2RA,IL2RG,IL5,IL5RA,CSF2,IL3
35	Autoimmune disease 1	C0004364	11	890	2.04983807706e-11	1.7838939857288483e-05	JAK3,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL2RG,STAT5B,STAT5A,CSF2
36	Acute myeloid leukemia	C0023467	15	1733	2.12130313315e-11	1.834862385321101e-05	JAK3,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,STAT5B,STAT5A,CSF2RB,IL3RA,CSF2,INPP5D,IL3
37	Adult T-Cell Lymphoma/Leukemia	C0023493	11	469	2.12366790819e-11	1.8858307849133536e-05	JAK3,IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,STAT5B,STAT5A,CSF2,IL3
38	Bronchiolitis, Viral	C0006274	10	211	2.19637641408e-11	1.9367991845056064e-05	IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,IL5RA,STAT5A,CSF2,IL3
39	Eczema	C0013595	9	474	2.20540252727e-11	1.9877675840978592e-05	IL2RB,IL2,IL2RA,JAK1,IL5,IL5RA,STAT5B,STAT5A,CSF2
40	Severe combined immunodeficiency due to ADA deficiency	C0085110	10	545	2.34164909685e-11	2.0387359836901124e-05	JAK3,IL2RB,NRAS,IL2,IL2RA,IL2RG,IL5,STAT5A,CSF2,IL3
41	Sarcoma, Ewing	C1261473	10	829	2.53905785286e-11	2.0897043832823652e-05	CSF2RA,SOS1,NRAS,IL2RG,IL5,STAT5B,STAT5A,CSF2RB,IL3RA,CSF2
42	Leukemogenesis	C0598766	12	660	2.56386023523e-11	2.1406727828746177e-05	JAK3,SOS1,NRAS,IL2,IL2RA,JAK1,IL2RG,STAT5B,STAT5A,IL3RA,CSF2,IL3
43	Immunodeficiency due to defect in CD3-gamma	C0021051	10	571	2.87069257254e-11	2.1916411824668705e-05	JAK3,IL2RB,IL2,IL2RA,IL2RG,STAT5B,STAT5A,IL3RA,CSF2,IL3
44	Cutaneous T-cell lymphoma	C0079773	8	255	3.1651348209e-11	2.2426095820591233e-05	JAK3,IL2,IL2RA,JAK1,IL5,STAT5B,STAT5A,CSF2
46	Sezary Syndrome	C0036920	6	151	3.68363117786e-11	2.344546381243629e-05	NRAS,IL2,IL2RG,IL5,STAT5B,STAT5A
47	Eosinophilic disorder	C1306759	6	143	3.80946385548e-11	2.3955147808358818e-05	IL2,IL2RA,IL5,IL5RA,CSF2,IL3
48	T-cell acute lymphoblastic leukemias	C1961099	8	371	4.02906596975e-11	2.4464831804281346e-05	JAK3,NRAS,IL2,IL2RA,JAK1,IL2RG,CSF2,INPP5D
49	Chronic Lymphocytic Leukemia	C0023434	13	1176	4.46446213331e-11	2.4974515800203874e-05	JAK3,CSF2RA,NRAS,IL2,IL2RA,JAK1,IL2RG,IL5,IL5RA,STAT5B,STAT5A,CSF2,IL3
50	Tropical Spastic Paraparesis	C0030481	5	58	4.48954207144e-11	2.54841997961264e-05	IL2RB,IL2,IL2RA,IL2RG,CSF2
51	Myeloid leukemia	C0023470	13	533	4.55474546968e-11	2.599388379204893e-05	JAK3,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,STAT5B,STAT5A,CSF2,INPP5D,IL3
52	Premature Birth	C0151526	8	376	5.22988319318e-11	2.650356778797146e-05	IL2RB,IL2,IL2RA,IL5,IL5RA,IL3RA,CSF2,IL3
53	Undifferentiated leukemia	C1378511	5	76	5.46350742425e-11	2.7013251783893987e-05	NRAS,IL2RA,STAT5B,STAT5A,IL3
54	Essential thrombocythemia	C0040028	6	150	5.48873169137e-11	2.7522935779816515e-05	NRAS,JAK1,STAT5B,STAT5A,CSF2,IL3
55	Disorder characterized by eosinophilia	C1636667	6	141	5.62523361225e-11	2.803261977573904e-05	IL2,IL2RA,IL5,IL5RA,CSF2,IL3
56	Hypereosinophilic syndrome	C1540912	5	26	5.71405145422e-11	2.854230377166157e-05	IL2,IL5,IL5RA,CSF2,IL3
57	Rheumatoid arthritis	C0003873	13	1856	6.19905238253e-11	2.90519877675841e-05	JAK3,SOS1,IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,IL5RA,STAT5B,STAT5A,CSF2,IL3
58	Premature Obstetric Labor	C0022876	7	203	6.37109254242e-11	2.9561671763506628e-05	IL2,IL2RA,IL5,IL5RA,IL3RA,CSF2,IL3
59	Idiopathic hypereosinophilic syndrome	C0206141	4	28	6.39414077241e-11	3.0071355759429153e-05	IL2,IL5,CSF2,IL3
60	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	10	854	6.80621115023e-11	3.0581039755351684e-05	JAK3,NRAS,IL2,IL2RA,JAK1,STAT5B,STAT5A,IL3RA,CSF2,IL3
61	Asthma	C0004096	12	1454	6.85557166591e-11	3.109072375127421e-05	JAK3,IL2RB,IL2,IL2RA,JAK1,IL2RG,IL5,IL5RA,STAT5A,CSF2RB,CSF2,IL3
62	Symptomatic human immunodeficiency virus infection	C0019693	13	1900	6.89589496616e-11	3.160040774719674e-05	GRB2,IL2RB,NRAS,IL2,IL2RA,JAK1,IL2RG,IL5,SHC1,STAT5B,STAT5A,CSF2,IL3
63	Acute lymphoid leukemia	C0023449	10	824	7.36164462722e-11	3.211009174311927e-05	JAK3,NRAS,IL2,JAK1,STAT5B,STAT5A,IL3RA,CSF2,INPP5D,IL3
64	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	8	385	7.51575468527e-11	3.26197757390418e-05	JAK3,NRAS,IL2,IL2RA,IL2RG,STAT5B,STAT5A,IL3
65	Chronic eosinophilic leukemia	C0346421	7	35	7.78814790436e-11	3.3129459734964325e-05	IL2,IL5,IL5RA,STAT5B,STAT5A,CSF2,IL3
66	Dermatitis, Atopic	C0011615	9	567	7.86477549752e-11	3.3639143730886846e-05	IL2RB,IL2,IL2RA,JAK1,IL5,IL5RA,STAT5B,STAT5A,CSF2
67	Hematological neoplasm	C0376545	9	615	7.89573961768e-11	3.4148827726809375e-05	JAK3,NRAS,IL2,JAK1,IL2RG,STAT5B,STAT5A,CSF2,IL3
68	Fetal Membranes, Premature Rupture	C0015943	7	194	8.49595949148e-11	3.46585117227319e-05	IL2,IL2RA,IL5,IL5RA,IL3RA,CSF2,IL3
69	Acute Undifferentiated Leukemia	C0280141	5	81	8.54678550155e-11	3.516819571865444e-05	NRAS,IL2RA,STAT5B,STAT5A,IL3
70	Myeloproliferative disorder (2)	C1292778	6	165	1.19519505404e-10	3.5677879714576966e-05	NRAS,JAK1,STAT5B,STAT5A,CSF2,INPP5D
71	Allergic rhinitis	C2607914	6	174	1.68466907091e-10	3.6187563710499494e-05	IL2RB,IL2,IL2RA,IL5,CSF2,IL3
72	X-linked severe combined immunodeficiency	C1279481	4	35	1.94998794889e-10	3.669724770642202e-05	JAK3,IL2,JAK1,IL2RG
73	Graft-versus-host disease, susceptibility to	C0018133	7	317	2.26449192731e-10	3.720693170234455e-05	JAK3,IL2,IL2RA,IL2RG,IL5,CSF2,INPP5D
74	Primary Myelofibrosis	C0001815	6	179	2.26563212635e-10	3.771661569826707e-05	JAK3,NRAS,JAK1,STAT5B,STAT5A,CSF2
75	Alveolar proteinosis	C0034050	4	40	2.49790077511e-10	3.82262996941896e-05	CSF2RA,IL5,CSF2RB,CSF2
76	Polycythemia vera	C0032463	6	192	2.93534085927e-10	3.873598369011213e-05	NRAS,JAK1,STAT5B,STAT5A,CSF2,IL3
77	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	C0021053	6	197	3.46526252137e-10	3.9245667686034656e-05	IL2,IL2RA,IL5,STAT5B,CSF2,IL3
78	Lymphoma, Large B-Cell, Diffuse	C0024299	11	1362	4.04143829513e-10	3.9755351681957185e-05	JAK3,SOS1,NRAS,IL2,IL2RA,JAK1,IL2RG,IL5,STAT5B,STAT5A,CSF2
79	Acute megakaryocytic leukemia	C0023462	5	106	4.34798641535e-10	4.026503567787971e-05	JAK3,NRAS,IL2,CSF2,IL3
85	Preeclampsia/eclampsia 1	C0032914	7	371	7.54024287453e-10	4.332313965341488e-05	IL2,IL2RA,IL5,IL5RA,IL3RA,CSF2,IL3
86	Severe congenital neutropenia	C1853118	4	50	7.67392926981e-10	4.383282364933741e-05	STAT5B,STAT5A,CSF2,IL3
87	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	10	1111	8.35806424071e-10	4.434250764525994e-05	IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,IL5RA,IL3RA,CSF2,IL3
88	Refractory anemia	C0002893	4	55	1.28951693767e-09	4.4852191641182466e-05	NRAS,IL5,CSF2,IL3
89	Melanoma	C0025202	13	2386	1.29247568204e-09	4.5361875637104995e-05	JAK3,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL2RG,IL5,SHC1,STAT5B,CSF2,IL3
90	Respiratory tract infection	C0035243	7	404	1.45586709355e-09	4.587155963302753e-05	JAK3,INPPL1,NRAS,IL2,IL2RA,IL2RG,IL5
91	Malignant neoplasm of lung	C0242379	13	2460	1.97755056774e-09	4.638124362895006e-05	JAK3,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,IL5RA,SHC1,STAT5B,CSF2,IL3
92	Hormone receptor positive tumor	C1446409	4	61	2.16609630233e-09	4.689092762487258e-05	IL2RA,STAT5B,STAT5A,CSF2
93	Acute promyelocytic leukemia	C0023487	7	431	2.38991859636e-09	4.740061162079511e-05	SOS1,NRAS,JAK1,STAT5B,STAT5A,CSF2,IL3
94	Tuberculosis	C0041296	8	652	2.56371468499e-09	4.7910295616717635e-05	GRB2,IL2RB,IL2,IL2RA,IL5,STAT5B,IL3RA,CSF2
95	B-cell lymphoma	C0079731	8	652	2.56371468499e-09	4.8419979612640164e-05	NRAS,IL2,IL2RA,IL5,STAT5B,STAT5A,CSF2,INPP5D
96	Hepatocellular carcinoma	C2239176	14	3108	3.38115313525e-09	4.892966360856269e-05	GRB2,INPPL1,SOS1,IL2RB,NRAS,IL2,IL2RA,JAK1,IL5,SHC1,STAT5B,STAT5A,CSF2,IL3
97	Neoplasm of the liver	C0023903	10	1290	3.96579935558e-09	4.943934760448522e-05	SOS1,NRAS,IL2,JAK1,IL5,SHC1,STAT5B,STAT5A,CSF2,IL3
98	{Atopy, susceptibility to}, 147050 (3)	C0392707	4	71	4.61193494505e-09	4.994903160040775e-05	IL2,IL5,CSF2,IL3
99	Crohn Disease	C0010346	9	979	4.67158978168e-09	5.0458715596330276e-05	GRB2,IL2,IL2RA,SHC1,STAT5B,STAT5A,IL3RA,CSF2,IL3
100	Pneumonia	C0032285	7	471	4.78995787478e-09	5.09683995922528e-05	JAK3,IL2RB,IL2,IL2RG,IL5,IL5RA,CSF2
101	Inflammatory Bowel Diseases	C0021390	9	985	4.9512729472e-09	5.147808358817533e-05	JAK3,SOS1,IL2RB,IL2,IL2RA,JAK1,IL5,CSF2,IL3
102	Leukopenia	C0023530	6	301	6.05782768393e-09	5.198776758409786e-05	IL2,IL2RA,IL2RG,STAT5B,CSF2,IL3
103	Hepatitis C	C0019196	8	721	6.09528216788e-09	5.249745158002039e-05	GRB2,SOS1,IL2RB,IL2,JAK1,STAT5A,CSF2,INPP5D
105	Bronchial Hyperreactivity	C0085129	5	170	7.22648219043e-09	5.3516819571865445e-05	IL2RB,IL5,IL5RA,CSF2,IL3
106	{Diphtheria, susceptibility to} (1)	C0012546	4	83	1.02443220573e-08	5.4026503567787974e-05	IL2,IL2RA,CSF2,IL3
107	Chronic Periodontitis	C0266929	5	182	1.08833342338e-08	5.45361875637105e-05	IL2,IL2RA,IL5,CSF2,INPP5D
108	Hydrops, lactic acidosis, and sideroblastic anemia	C0013604	6	335	1.2666235949e-08	5.504587155963303e-05	INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
112	Secondary hypertriglyceridemia	C0027627	14	3444	1.39756662909e-08	5.708460754332314e-05	JAK3,GRB2,INPPL1,SOS1,IL2RB,NRAS,IL2,JAK1,IL2RG,IL5,SHC1,STAT5B,STAT5A,CSF2
113	Leishmaniasis, Visceral	C0023290	4	89	1.45137835084e-08	5.759429153924567e-05	IL2RB,IL2,IL2RA,CSF2
114	Diabetes mellitus type 1	C0011854	9	1104	1.46547781688e-08	5.81039755351682e-05	INPPL1,IL2RB,NRAS,IL2,IL2RA,STAT5B,STAT5A,CSF2,IL3
115	Abnormality of fluid regulation	C2364164	6	346	1.58145984086e-08	5.861365953109073e-05	INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
116	Acute Erythroblastic Leukemia	C0023440	5	195	1.63895423899e-08	5.9123343527013255e-05	INPPL1,NRAS,STAT5B,STAT5A,CSF2
117	Histiocytic medullary reticulosis	C0019623	3	32	1.74986813928e-08	5.9633027522935784e-05	IL2RA,IL2RG,IL5
118	Allergic asthma	C0155877	5	200	1.90971253256e-08	6.0142711518858305e-05	IL2,IL2RA,IL5,CSF2,IL3
119	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	7	568	2.04563348483e-08	6.065239551478083e-05	JAK3,SOS1,NRAS,IL2,IL5,INPP5D,IL3
120	Schizophrenia	C0036341	11	1947	2.21801146338e-08	6.116207951070337e-05	GRB2,CSF2RA,SOS1,IL2RB,IL2,IL2RA,IL2RG,CSF2RB,IL3RA,CSF2,IL3
123	Mumps	C0026780	3	35	2.55075355282e-08	6.269113149847094e-05	IL2RB,IL2RA,CSF2
124	Allergic disposition	C3539909	5	210	2.55275605099e-08	6.320081549439348e-05	IL2,IL2RA,IL5,CSF2,IL3
125	Myelofibrosis	C0026987	4	102	2.89000978704e-08	6.3710499490316e-05	JAK1,STAT5B,STAT5A,CSF2
126	Dermatitis and eczema	C0477474	3	37	3.20691480038e-08	6.422018348623854e-05	IL5,IL5RA,CSF2
132	Prostatic Neoplasms	C0033578	10	1606	3.82943997623e-08	6.727828746177369e-05	SOS1,NRAS,IL2,IL2RA,JAK1,SHC1,STAT5B,STAT5A,CSF2,IL3
133	Myelodysplastic syndrome	C3463824	6	399	4.19197047075e-08	6.778797145769623e-05	JAK3,NRAS,JAK1,IL5,CSF2,IL3
134	Hairy Cell Leukemia	C0023443	4	110	4.23148466266e-08	6.829765545361875e-05	IL2RB,IL2,IL2RA,IL3
135	Idiopathic thrombocytopenic purpura	C0398650	4	111	4.4266021626e-08	6.880733944954129e-05	NRAS,IL2,IL2RA,JAK1
136	Dermatitis, Allergic Contact	C0162820	4	111	4.4266021626e-08	6.93170234454638e-05	IL2,IL2RA,IL5,CSF2
137	Hay fever	C0018621	4	114	5.05876570633e-08	6.982670744138635e-05	IL2,IL5,CSF2RB,CSF2
138	Sinusitis	C0037199	4	114	5.05876570633e-08	7.033639143730888e-05	IL2RG,IL5,CSF2,IL3
139	Chronic myelomonocytic leukemia	C0023480	4	115	5.28572212666e-08	7.084607543323139e-05	GRB2,NRAS,IL3RA,CSF2
140	Immediate hypersensitivity	C0020523	4	117	5.75890113375e-08	7.135575942915393e-05	IL5,IL5RA,CSF2,IL3
141	Abnormality of lung morphology	C4021760	7	651	5.85977809608e-08	7.186544342507645e-05	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG,CSF2RB
142	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	C0013336	8	949	6.5083501477e-08	7.237512742099899e-05	CSF2RA,INPPL1,SOS1,NRAS,STAT5B,IL3RA,CSF2,IL3
143	Abnormality of the lymphatic system	C4021976	6	426	6.54898871799e-08	7.28848114169215e-05	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG
144	Lymphopenia	C0024312	4	122	7.11431091815e-08	7.339449541284404e-05	JAK3,IL2,IL2RA,IL2RG
145	Lymphoid leukemia	C0023448	5	252	7.51579162239e-08	7.390417940876656e-05	GRB2,NRAS,IL2RA,IL3RA,IL3
146	Celiac Disease	C0007570	6	436	7.67183818695e-08	7.44138634046891e-05	IL2RB,IL2,IL2RA,IL5,IL5RA,IL3
147	Fibrosarcoma	C0016057	5	254	7.87783154266e-08	7.492354740061162e-05	IL2RB,NRAS,IL2,JAK1,CSF2
148	Anterior uveitis	C0042165	3	48	9.38157402874e-08	7.543323139653414e-05	IL2RB,IL2,IL2RA
149	Giant cell arteritis	C0039483	4	129	9.40019534434e-08	7.594291539245669e-05	IL2,IL2RA,CSF2,IL3
150	Anaplastic large cell lymphoma, ALK negative	C0206180	5	263	9.67743689628e-08	7.64525993883792e-05	JAK3,IL2,IL2RA,JAK1,CSF2
151	Abnormality of the lymph nodes	C0149727	4	130	9.77275763647e-08	7.696228338430174e-05	JAK3,NRAS,IL2RA,IL2RG
152	Hepatitis C, Chronic	C0524910	6	455	1.02497180854e-07	7.747196738022426e-05	IL2,IL2RA,JAK1,IL5,CSF2,INPP5D
153	Musculoskeletal Diseases	C0026857	4	132	1.05421587682e-07	7.79816513761468e-05	IL2RB,IL2,IL2RA,IL5
154	Pregnancy Complications, Hematologic	C0032964	4	133	1.09438921037e-07	7.849133537206931e-05	IL2RB,IL2,IL2RA,IL5
155	Malignant tumor of urinary bladder	C0005684	9	1371	1.13052857187e-07	7.900101936799185e-05	JAK3,GRB2,SOS1,NRAS,IL2,IL5,IL5RA,CSF2,IL3
156	Abnormal immunoglobulin level	C1855755	4	134	1.13684626935e-07	7.951070336391437e-05	JAK3,NRAS,IL2RA,IL2RG
157	Abnormality of B cells	C4021748	4	136	1.22364599453e-07	8.00203873598369e-05	JAK3,NRAS,IL2RA,IL2RG
158	Abnormality of B cell physiology	C1849242	4	136	1.22364599453e-07	8.053007135575943e-05	JAK3,NRAS,IL2RA,IL2RG
159	Pleural effusion	C0032227	4	137	1.26953123236e-07	8.103975535168195e-05	SOS1,IL2,IL2RA,IL5
160	Rhinitis, Allergic, Seasonal	C0035455	4	138	1.31666836545e-07	8.15494393476045e-05	IL2RA,IL5,CSF2,IL3
163	Urticaria Pigmentosa	C0042111	3	53	1.40779915947e-07	8.307849133537207e-05	IL2RA,STAT5B,STAT5A
164	Acute GVH disease	C0856825	4	140	1.41468145642e-07	8.358817533129461e-05	IL2,IL2RA,IL5,INPP5D
165	Hematological Disease	C0018939	4	143	1.57223475461e-07	8.409785932721712e-05	JAK3,NRAS,CSF2,IL3
169	Mastocytosis	C0024899	3	57	1.89421855756e-07	8.613659531090725e-05	IL2RA,STAT5B,STAT5A
170	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	C0221013	3	58	2.0329309991e-07	8.664627930682976e-05	IL2RA,STAT5B,STAT5A
171	Lymphocytic Choriomeningitis	C0024266	3	58	2.0329309991e-07	8.71559633027523e-05	IL2RA,CSF2,IL3
172	Fetal Diseases	C0015929	4	151	2.06198081609e-07	8.766564729867482e-05	IL2RB,IL2,IL2RA,IL5
173	Bladder carcinoma	C0699885	8	1087	2.06849427808e-07	8.817533129459736e-05	GRB2,SOS1,NRAS,IL2,IL5,IL5RA,CSF2,IL3
174	Uveitis	C0042164	4	154	2.27428145982e-07	8.868501529051988e-05	IL2RB,IL2,IL2RA,CSF2
177	Abnormal respiratory system morphology	C4022992	7	778	2.29434248933e-07	9.021406727828746e-05	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG,CSF2RB
178	Measles	C0025007	4	155	2.34943220989e-07	9.072375127420999e-05	IL2RB,IL2,IL2RA,CSF2
179	Abnormality of humoral immunity	C3150510	4	157	2.50323071271e-07	9.123343527013252e-05	JAK3,NRAS,IL2RA,IL2RG
180	Monosomy	C0026499	4	158	2.58399454389e-07	9.174311926605506e-05	NRAS,STAT5B,STAT5A,IL3RA
181	Nonalcoholic Steatohepatitis	C3241937	4	158	2.58399454389e-07	9.225280326197757e-05	IL2RB,IL2RA,CSF2,IL3
182	Abnormality of the respiratory system	C4018871	8	1121	2.68477556298e-07	9.276248725790012e-05	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG,STAT5B,CSF2RB
183	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	3	63	2.84556347596e-07	9.327217125382263e-05	SOS1,NRAS,CSF2
186	Recurrent respiratory infections	C3806482	5	318	2.9591105799e-07	9.480122324159021e-05	JAK3,INPPL1,NRAS,IL2RA,IL2RG
187	Tumor Progression	C0178874	10	1969	3.07221421303e-07	9.531090723751274e-05	GRB2,SOS1,NRAS,IL2,IL2RA,JAK1,IL5,STAT5B,STAT5A,CSF2
188	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	C0041408	4	164	3.10923051194e-07	9.582059123343527e-05	CSF2RA,IL3RA,CSF2,IL3
189	Diabetes mellitus type 2	C0011860	10	1972	3.12020301929e-07	9.63302752293578e-05	GRB2,INPPL1,SOS1,IL2,IL2RA,IL5,IL5RA,SHC1,STAT5A,CSF2
195	Squamous cell carcinoma of the head and neck	C1168401	7	825	3.58418560387e-07	9.938837920489297e-05	SOS1,IL2,IL2RA,JAK1,STAT5B,STAT5A,CSF2
196	Tumor necrosis	C0333516	4	170	3.71634692797e-07	9.98980632008155e-05	IL2RB,IL2,JAK1,CSF2
197	Metastatic melanoma	C0278883	5	333	3.87643796618e-07	0.00010040774719673802	SOS1,NRAS,IL2,STAT5A,CSF2
198	Aplastic anemia	C0002874	4	172	3.93825974387e-07	0.00010091743119266055	NRAS,IL2,IL2RA,CSF2
199	Non-Hodgkin lymphoma	C0024305	6	556	3.97628426074e-07	0.00010142711518858308	IL2,IL2RA,IL5,STAT5B,STAT5A,CSF2
200	Carcinogenesis	C0596263	13	3723	4.10472395407e-07	0.0001019367991845056	JAK3,GRB2,SOS1,NRAS,IL2,IL2RA,IL5,SHC1,STAT5B,STAT5A,CSF2,INPP5D,IL3
201	Lymphocytosis	C0024282	3	69	4.11470752804e-07	0.00010244648318042814	IL2,IL5,CSF2
203	Wiskott-Aldrich syndrome, 301000 (3)	C0043194	3	70	4.36156240569e-07	0.0001034658511722732	IL2,IL2RG,CSF2
204	Bronchiolitis	C0006271	3	70	4.36156240569e-07	0.00010397553516819572	IL2,IL2RA,IL5
205	Chronic Chagas' disease	C0041234	4	176	4.4135302435e-07	0.00010448521916411825	IL2RB,IL2,IL2RA,CSF2
206	Thymoma	C0040100	4	176	4.4135302435e-07	0.00010499490316004078	NRAS,IL2,IL2RA,CSF2
207	Abnormality of the spleen	C4025749	5	347	4.9326653484e-07	0.0001055045871559633	INPPL1,SOS1,NRAS,IL2RA,IL2RG
208	Seborheic dermatitis	C0011603	4	181	5.07052497212e-07	0.00010601427115188583	IL2RA,IL5,STAT5B,STAT5A
209	Neuroblastoma	C0700095	9	1612	5.1058764805e-07	0.00010652395514780835	GRB2,IL2RB,NRAS,IL2,IL2RA,STAT5B,STAT5A,CSF2,IL3
213	Secondary hyperparathyroidism	C0020503	4	182	5.21063608372e-07	0.00010856269113149848	IL2RB,IL2,IL2RA,IL3
214	Diabetes Mellitus, Type 1	C0011849	10	2081	5.37034718917e-07	0.000109072375127421	INPPL1,SOS1,IL2RB,IL2,IL2RA,SHC1,STAT5B,STAT5A,CSF2,IL3
215	Acute monocytic leukemia	C0023465	3	75	5.76487637405e-07	0.00010958205912334353	IL2,IL2RG,CSF2
216	Paroxysmal nocturnal hemoglobinuria	C0024790	3	75	5.76487637405e-07	0.00011009174311926606	NRAS,IL2,CSF2
219	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	C2939461	3	76	6.08105946709e-07	0.00011162079510703364	STAT5B,STAT5A,CSF2
220	Glioblastoma	C0017636	9	1645	6.15625606049e-07	0.00011213047910295616	INPPL1,SOS1,NRAS,IL2,IL2RA,SHC1,STAT5B,STAT5A,CSF2
221	Breast-ovarian cancer, familial 1	C0006142	14	4543	6.16098721484e-07	0.0001126401630988787	JAK3,GRB2,INPPL1,SOS1,NRAS,IL2,IL2RA,JAK1,IL5,SHC1,STAT5B,STAT5A,CSF2,IL3
222	Aortic Aneurysm, Abdominal	C0162871	4	190	6.44574709607e-07	0.00011314984709480123	IL2RA,STAT5B,STAT5A,CSF2
223	Abnormality of lymphocytes	C0427546	4	194	7.14490318243e-07	0.00011365953109072376	JAK3,NRAS,IL2RA,IL2RG
225	Connective Tissue Diseases	C0009782	4	196	7.51503287377e-07	0.00011467889908256881	IL2RB,IL2,IL2RA,IL5
226	Graves Disease	C0018213	5	374	7.63794561265e-07	0.00011518858307849134	GRB2,IL2,IL2RA,IL5,IL3
247	IMMUNE SUPPRESSION	C0021079	3	81	7.86246312723e-07	0.00012589194699286443	JAK3,IL2RA,CSF2
248	Kidney Failure, Chronic	C0022661	6	616	7.9094687544e-07	0.00012640163098878696	SOS1,IL2,IL2RA,SHC1,CSF2,IL3
249	Pulmonary Disease, Chronic Obstructive	C0024115	5	377	8.00108636345e-07	0.0001269113149847095	IL2,IL2RA,IL5,STAT5B,CSF2
253	Chlamydia Infections	C0008149	3	83	8.67441260155e-07	0.0001289500509683996	IL5RA,SHC1,CSF2
254	Adult type dermatomyositis	C0221056	3	83	8.67441260155e-07	0.00012945973496432213	IL2,IL2RA,CSF2
255	Carcinoma, Lewis Lung	C0243038	3	83	8.67441260155e-07	0.00012996941896024463	IL2,IL2RG,CSF2
256	Anemia	C0002871	6	627	8.90364846517e-07	0.0001304791029561672	NRAS,IL2,IL2RA,IL2RG,CSF2,IL3
257	CNS infection	C0007684	3	84	9.10220541162e-07	0.00013098878695208972	JAK3,IL2RG,CSF2
258	Dental malocclusion	C0024636	3	85	9.54592115354e-07	0.00013149847094801224	SOS1,IL2RB,IL2RA
259	Experimental Autoimmune Encephalomyelitis	C0014072	5	389	9.60222153346e-07	0.00013200815494393474	IL2RB,IL2,IL2RA,IL5,CSF2
260	Colon cancer	C0007102	9	1727	9.63324178982e-07	0.0001325178389398573	JAK3,INPPL1,SOS1,NRAS,IL2,IL2RG,STAT5B,STAT5A,CSF2
263	Ovarian Neoplasms	C0919267	7	942	9.77007511227e-07	0.00013404689092762486	GRB2,SOS1,NRAS,IL2,STAT5B,STAT5A,CSF2
264	Wheezing	C0043144	3	86	1.00058920693e-06	0.00013455657492354739	IL2,IL2RA,IL5
265	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	C0034069	5	392	1.00409983061e-06	0.00013506625891946994	SOS1,IL2,IL2RA,IL5,CSF2
266	Neoplasm, Residual	C0242596	4	208	1.00743557063e-06	0.00013557594291539247	IL2,IL3RA,CSF2,IL3
267	Hepatomegaly	C0019209	5	397	1.08081680739e-06	0.000136085626911315	INPPL1,SOS1,NRAS,IL2RA,IL2RG
268	Leprosy	C0023343	4	211	1.0810578176e-06	0.0001365953109072375	IL2,IL2RA,IL5,IL5RA
269	Inflammation	C0021368	6	647	1.09805076298e-06	0.00013710499490316005	IL2RB,IL2,IL2RA,IL5,IL5RA,CSF2
272	Decreased antibody level in blood	C4048270	3	91	1.25554166985e-06	0.0001386340468909276	JAK3,IL2RA,IL2RG
274	Tuberculosis, Pulmonary	C0041327	4	218	1.26941102552e-06	0.0001396534148827727	IL2,IL2RA,IL5,CSF2
275	Hodgkin Disease	C0019829	5	409	1.28481449269e-06	0.00014016309887869522	SOS1,IL2,IL5,STAT5B,STAT5A
276	Epstein-Barr Virus Infections	C0149678	4	219	1.29831355999e-06	0.00014067278287461775	IL2,IL2RA,IL5,CSF2
277	Brain neoplasm	C0006118	6	667	1.34513124617e-06	0.00014118246687054025	NRAS,IL2,IL2RG,STAT5B,STAT5A,CSF2
278	Lymphedema, primary, with myelodysplasia	C0024236	3	93	1.37005706979e-06	0.00014169215086646278	INPPL1,SOS1,NRAS
279	Chronic graft-versus-host disease	C0867389	3	93	1.37005706979e-06	0.00014220183486238534	IL2,IL2RA,IL5
280	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	6	671	1.39980467784e-06	0.00014271151885830786	SOS1,IL2,IL2RA,IL2RG,STAT5B,STAT5A
281	Hypsarrhythmia	C0037769	3	94	1.43007128472e-06	0.00014322120285423036	SOS1,IL2RG,CSF2
282	Severe Aplastic Anemia	C1883018	2	25	1.43777884698e-06	0.0001437308868501529	CSF2,IL3
283	Elevated C-reactive protein level	C4023452	2	25	1.43777884698e-06	0.00014424057084607545	IL2RB,IL2RA
284	Respiratory failure	C1145670	5	418	1.45769755855e-06	0.00014475025484199798	INPPL1,IL5,CSF2RB,CSF2,IL3
285	Waldenstrom macroglobulinemia	C0024419	3	96	1.55597434159e-06	0.0001452599388379205	IL2RA,STAT5B,STAT5A
286	Autoimmune antibody positivity	C4022660	2	26	1.62436169426e-06	0.000145769622833843	IL2RB,IL2RA
287	Lipomatosis, Multiple	C3489413	2	26	1.62436169426e-06	0.00014627930682976553	STAT5B,STAT5A
288	Abnormal erythrocyte sedimentation rate	C0438217	2	26	1.62436169426e-06	0.0001467889908256881	IL2RB,IL2RA
289	Animal Mammary Neoplasms	C0024667	10	2352	1.82653369907e-06	0.00014729867482161062	GRB2,INPPL1,SOS1,IL2,IL2RA,JAK1,SHC1,STAT5B,STAT5A,CSF2
290	Carcinoma of colon	C0699790	9	1856	1.86206567976e-06	0.00014780835881753312	JAK3,INPPL1,SOS1,NRAS,IL2,IL2RG,STAT5B,STAT5A,CSF2
291	Nasal polyposis	C0027430	4	236	1.87417137665e-06	0.00014831804281345565	JAK3,IL2,IL5,CSF2
292	Polymyositis	C0085655	3	102	1.98334087143e-06	0.0001488277268093782	SOS1,IL2,IL2RA
293	Fowlpox	C0016629	2	28	2.04425491379e-06	0.00014933741080530073	IL2,CSF2
294	Malignant neoplasm of vulva	C0375071	2	28	2.04425491379e-06	0.00014984709480122323	IL2,CSF2
295	Bacteremia, susceptibility to, 2	C0004610	3	104	2.14345775862e-06	0.00015035677879714576	IL2,IL5,CSF2
296	Tumor Immunity	C1519680	3	105	2.22705046826e-06	0.0001508664627930683	IL2,IL2RA,CSF2
297	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	3	105	2.22705046826e-06	0.00015137614678899084	SOS1,NRAS,CSF2
298	Cystic hygroma	C0206620	2	29	2.27880921211e-06	0.00015188583078491337	SOS1,NRAS
299	Meningioma	C0025286	5	452	2.29157131681e-06	0.00015239551478083587	JAK3,GRB2,NRAS,JAK1,CSF2
316	Precancerous Conditions	C0032927	5	455	2.38073458803e-06	0.00016106014271151885	SOS1,NRAS,IL2,IL2RA,STAT5A
317	Gastric Mucosa-Associated Lymphoid Tissue Lymphoma	C1333782	2	30	2.53047371779e-06	0.00016156982670744138	IL2,IL2RA
318	Aplasia/Hypoplasia of the abdominal wall musculature	C4023909	2	30	2.53047371779e-06	0.0001620795107033639	SOS1,NRAS
319	Elevated erythrocyte sedimentation rate	C0151632	2	30	2.53047371779e-06	0.00016258919469928646	IL2RB,IL2RA
320	Lupus Erythematosus, Systemic	C0024141	8	1467	2.55060095844e-06	0.000163098878695209	SOS1,IL2RB,IL2,IL2RA,JAK1,IL5,STAT5A,CSF2
321	Visceromegaly	C0042782	5	461	2.5676350669e-06	0.0001636085626911315	INPPL1,SOS1,NRAS,IL2RA,IL2RG
322	Thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis	C0040034	4	253	2.63487563201e-06	0.00016411824668705402	NRAS,JAK1,CSF2,IL3
323	Neutropenia	C0027947	4	255	2.73835225528e-06	0.00016462793068297655	NRAS,JAK1,STAT5B,CSF2
324	Synovitis	C0039103	3	111	2.78027762812e-06	0.0001651376146788991	IL2,CSF2,IL3
325	Sarcoidosis	C0036202	4	257	2.84494306002e-06	0.0001656472986748216	IL2,IL2RA,IL5,CSF2
326	Opportunistic Infections	C0029118	2	32	3.08780064184e-06	0.00016615698267074413	IL2,CSF2
327	Decrease in T cell count	C0392756	2	32	3.08780064184e-06	0.00016666666666666666	IL2RA,IL2RG
328	Primary biliary cirrhosis	C0008312	4	263	3.18452415349e-06	0.00016717635066258922	SOS1,IL2,IL2RA,IL5
329	Dermatomyositis	C0011633	3	115	3.20173527979e-06	0.00016768603465851174	IL2,IL2RA,CSF2
330	Cutaneous malignant melanoma 3	C0151779	4	264	3.24404243413e-06	0.00016819571865443425	JAK3,NRAS,IL2RA,CSF2
331	Chronic atrophic gastritis	C0017154	3	116	3.3140980662e-06	0.00016870540265035677	IL2,IL2RA,CSF2
332	Malignant mesothelioma	C0345967	4	266	3.36584782445e-06	0.0001692150866462793	SOS1,IL2RB,IL2,CSF2
333	Solid tumour	C0280100	6	772	3.54539156344e-06	0.00016972477064220186	SOS1,IL2,IL2RA,IL2RG,STAT5A,CSF2
334	Ankylosing spondylitis	C0038013	4	269	3.55524413875e-06	0.00017023445463812436	IL2,IL2RA,IL2RG,CSF2RB
335	Hepatitis B, Chronic	C0524909	4	272	3.75289858645e-06	0.0001707441386340469	IL2,IL2RA,JAK1,CSF2
336	Malnutrition	C0162429	3	122	4.05095706901e-06	0.00017125382262996941	IL2,STAT5B,STAT5A
337	Ileitis	C0020877	2	35	4.06744503423e-06	0.00017176350662589197	IL5,CSF2
338	Abnormal platelet function	C0855740	2	35	4.06744503423e-06	0.0001722731906218145	SOS1,NRAS
339	Myelosuppression	C0854467	2	35	4.06744503423e-06	0.000172782874617737	CSF2,IL3
340	Hepatitis, Autoimmune	C0241910	3	123	4.18458683293e-06	0.00017329255861365953	IL2,IL2RA,IL5
341	Lymphadenopathy	C0497156	3	124	4.32146538254e-06	0.00017380224260958206	NRAS,IL2RA,IL2RG
342	Abnormality of abdomen morphology	C4020869	5	505	4.33833960156e-06	0.0001743119266055046	INPPL1,SOS1,NRAS,IL2RA,IL2RG
343	Anemia, severe	C0238644	2	36	4.43452758647e-06	0.0001748216106014271	IL2,IL3
344	Classical Hodgkin's Lymphoma	C1333064	3	126	4.60519479772e-06	0.00017533129459734964	IL2,STAT5B,STAT5A
369	Splenomegaly	C0038002	4	285	4.71145360414e-06	0.00018807339449541287	INPPL1,NRAS,IL2RA,IL2RG
370	Abnormality of the immune system	C4021753	7	1164	4.74037270914e-06	0.00018858307849133537	JAK3,INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
371	Abnormal urine phosphate concentration	C4022828	2	37	4.8230148405e-06	0.0001890927624872579	INPPL1,NRAS
372	Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations	C0239998	5	521	5.18801619476e-06	0.00018960244648318043	JAK3,INPPL1,NRAS,IL2RA,IL2RG
373	Common variable immunodeficiency 2	C0009447	3	130	5.21388768648e-06	0.00019011213047910298	IL2,IL2RA,IL5
374	Noninfiltrating Intraductal Carcinoma	C0007124	4	291	5.21407824616e-06	0.00019062181447502549	SOS1,NRAS,IL2RA,STAT5A
375	Lymphoma, AIDS-Related	C0085090	2	38	5.23331823987e-06	0.00019113149847094801	IL5,CSF2
376	Combined immunodeficiency, X-linked	C0494261	2	38	5.23331823987e-06	0.00019164118246687054	JAK3,IL2RG
377	Polyarticular arthritis	C0162323	2	38	5.23331823987e-06	0.00019215086646279307	IL2RB,IL2RA
378	Chromosome 5, trisomy 5q	C1802398	2	38	5.23331823987e-06	0.0001926605504587156	IL5,CSF2
379	Pregnancy Complications	C0032962	3	132	5.53952049853e-06	0.00019317023445463813	IL5,CSF2,IL3
380	Transitional cell carcinoma of the bladder	C0279680	3	132	5.53952049853e-06	0.00019367991845056065	NRAS,IL2,CSF2
381	Schwannoma	C0027809	3	132	5.53952049853e-06	0.00019418960244648318	IL2RB,STAT5B,STAT5A
382	Partial Trisomy	C1297882	2	39	5.66613082054e-06	0.0001946992864424057	IL3RA,IL3
383	Intracranial glioma	C3665419	2	39	5.66613082054e-06	0.00019520897043832824	SOS1,CSF2
384	Chronic diarrhea	C0401151	2	39	5.66613082054e-06	0.00019571865443425077	IL2RA,IL2RG
385	Superficial ulcer	C0333307	3	134	5.88005774793e-06	0.0001962283384301733	IL2RB,IL2,IL2RA
386	Hypophosphatemia	C0085682	2	40	6.12194221106e-06	0.00019673802242609582	INPPL1,NRAS
387	Recurrent fungal infections	C1844384	2	41	6.60141739139e-06	0.00019724770642201835	IL2RA,IL2RG
388	Primary Sjï¿½gren's syndrome	C0205225	2	42	7.10504016477e-06	0.00019775739041794088	STAT5B,STAT5A
389	Acute anterior uveitis	C0701807	2	42	7.10504016477e-06	0.0001982670744138634	IL2,IL2RA
390	Active tuberculosis	C0151332	2	42	7.10504016477e-06	0.00019877675840978594	IL2,IL2RA
391	Mammary Tumorigenesis	C1512981	3	141	7.19469425459e-06	0.00019928644240570846	GRB2,NRAS,STAT5A
392	Hashimoto thyroiditis	C0677607	3	142	7.39884016798e-06	0.000199796126401631	NRAS,IL2,IL2RA
393	Abnormality of cell physiology	C4023595	4	313	7.42788412667e-06	0.00020030581039755352	JAK3,NRAS,IL2RA,IL2RG
394	Ovarian epithelial cancer	C0677886	9	2172	7.70369484449e-06	0.00020081549439347605	SOS1,NRAS,IL2,IL2RA,JAK1,IL2RG,STAT5B,STAT5A,CSF2
421	Coarse hair	C0277959	2	44	8.18716999051e-06	0.0002145769622833843	SOS1,NRAS
422	Pulmonary artery stenosis	C0238397	2	44	8.18716999051e-06	0.0002150866462793068	SOS1,NRAS
423	Non-arthropod borne lymphocytic choriomeningitis	C0153014	2	44	8.18716999051e-06	0.00021559633027522937	IL2RA,CSF2
424	Subacute Sclerosing Panencephalitis	C0038522	2	44	8.18716999051e-06	0.0002161060142711519	IL2,CSF2
425	Short digit	C4023124	4	320	8.26817642019e-06	0.00021661569826707442	INPPL1,SOS1,NRAS,IL2RG
426	Malaria, Falciparum	C0024535	3	147	8.48445162038e-06	0.00021712538226299695	IL2,IL5,IL3
427	Arthropathy	C0022408	3	147	8.48445162038e-06	0.00021763506625891945	IL2RB,IL2,IL2RA
428	Abnormality of immune system physiology	C4023616	6	884	8.62643079513e-06	0.000218144750254842	JAK3,INPPL1,IL2RB,NRAS,IL2RA,IL2RG
429	Fibrous tissue neoplasm	C0206643	2	45	8.7668139902e-06	0.00021865443425076454	SOS1,NRAS
430	Mammary Carcinoma, Human	C1257930	2	45	8.7668139902e-06	0.00021916411824668706	STAT5B,STAT5A
431	Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper-ige	C0011606	2	45	8.7668139902e-06	0.00021967380224260956	IL2RG,IL5
432	Chondrodysplasia acromesomelic with genital anomalies	C0343284	2	45	8.7668139902e-06	0.00022018348623853212	STAT5B,STAT5A
433	Enlarged thorax	C4020962	2	45	8.7668139902e-06	0.00022069317023445465	SOS1,NRAS
434	Scleroderma	C0036421	5	573	8.9336890875e-06	0.00022120285423037718	SOS1,IL2RB,IL2,IL2RA,CSF2
435	CARCINOMA OF VULVA	C0677055	2	46	9.37300906079e-06	0.0002217125382262997	IL2,CSF2
436	Abdominal symptom	C0740651	6	901	9.76800448627e-06	0.0002222222222222222	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG
437	Nijmegen Breakage Syndrome	C0398791	2	47	1.00062039426e-05	0.00022273190621814476	IL2,IL5
438	Thickened nuchal skin fold	C1836940	2	47	1.00062039426e-05	0.0002232415902140673	SOS1,NRAS
439	Melanocytic nevus of skin	C3665593	2	47	1.00062039426e-05	0.00022375127420998982	SOS1,NRAS
440	Metastatic Renal Cell Cancer	C0278678	2	47	1.00062039426e-05	0.00022426095820591232	IL2,CSF2
441	Toxoplasmosis	C0040558	2	47	1.00062039426e-05	0.00022477064220183487	IL2,CSF2
442	Splenic Marginal Zone B-Cell Lymphoma	C0349632	2	49	1.13560233539e-05	0.0002252803261977574	IL2,IL2RA
443	IgA deficiency	C0162538	2	49	1.13560233539e-05	0.00022579001019367993	IL2RA,IL5
444	Carcinoma breast stage IV	C0278488	4	342	1.14035358606e-05	0.00022629969418960246	SOS1,IL2,STAT5B,CSF2
458	Rubella	C0035920	2	50	1.20737778453e-05	0.00023343527013251783	IL2RB,IL2RA
459	Progressive cGVHD	C3539781	3	161	1.21508144409e-05	0.00023394495412844038	NRAS,IL2,CSF2
460	Progressive Neoplastic Disease	C0677932	3	161	1.21508144409e-05	0.0002344546381243629	NRAS,IL2,CSF2
461	Pectus excavatum	C0016842	3	162	1.24510830471e-05	0.00023496432212028544	INPPL1,SOS1,NRAS
462	Disseminated Malignant Neoplasm	C0346957	3	162	1.24510830471e-05	0.00023547400611620794	JAK3,IL2,CSF2
463	Pemphigus	C0030807	2	51	1.2820900873e-05	0.00023598369011213047	IL2,IL5
464	Aural atresia, congenital	C1842937	2	51	1.2820900873e-05	0.00023649337410805302	NRAS,CSF2
465	Morphological abnormality of the inner ear	C4023381	2	51	1.2820900873e-05	0.00023700305810397555	SOS1,NRAS
466	Wilms Tumor	C0027708	4	352	1.3104681815e-05	0.00023751274209989808	SOS1,NRAS,IL2,CSF2
467	Secondary malignant neoplasm of lung	C0153676	5	614	1.32314636004e-05	0.00023802242609582058	GRB2,SOS1,NRAS,IL2,CSF2
468	Abnormality of phosphate homeostasis	C4022032	2	52	1.3597840189e-05	0.00023853211009174313	INPPL1,NRAS
469	Peptic Esophagitis	C0014869	2	52	1.3597840189e-05	0.00023904179408766566	IL2,IL5
470	Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	C0393819	2	52	1.3597840189e-05	0.0002395514780835882	IL2RA,CSF2
471	Guillain-Barre syndrome, familial	C0018378	2	52	1.3597840189e-05	0.0002400611620795107	IL2,IL2RA
472	Hematopoietic Neoplasms	C0376544	3	168	1.43686494133e-05	0.00024057084607543322	IL2,STAT5B,STAT5A
473	Zoonotic form of cutaneous leishmaniasis	C0023283	2	54	1.52437157692e-05	0.00024108053007135578	IL2,IL2RA
474	Abnormality of the abdominal musculature	C4023608	2	54	1.52437157692e-05	0.0002415902140672783	SOS1,NRAS
475	Fibroma	C0016045	2	54	1.52437157692e-05	0.00024209989806320083	SOS1,NRAS
476	Exanthema	C0015230	4	366	1.58128614693e-05	0.00024260958205912333	NRAS,IL2RG,IL5,CSF2
497	Breast carcinoma	C0678222	12	4281	1.68587298587e-05	0.0002533129459734964	JAK3,GRB2,INPPL1,SOS1,NRAS,IL2,IL2RA,JAK1,SHC1,STAT5B,STAT5A,CSF2
498	Autoimmune lymphoproliferative syndrome, type 2	C1328840	2	56	1.70158511319e-05	0.000253822629969419	NRAS,IL2RA
499	Radioulnar synostosis	C0158761	2	56	1.70158511319e-05	0.00025433231396534154	SOS1,NRAS
500	Endometriosis of uterus	C0341858	2	56	1.70158511319e-05	0.000254841997961264	SOS1,IL2RB
501	Lymphoma, Large-Cell, Follicular	C0079745	3	176	1.72535196838e-05	0.00025535168195718654	IL2,STAT5B,STAT5A
502	Abnormality of the uvea	C4025842	4	373	1.73212869796e-05	0.0002558613659531091	SOS1,IL2RB,NRAS,IL2RA
503	Female pseudohermaphroditism	C0238394	2	57	1.79507111426e-05	0.0002563710499490316	JAK3,JAK1
504	Chronic neutrophilia	C3665444	2	57	1.79507111426e-05	0.00025688073394495415	IL5,CSF2
505	Joint swelling	C0152031	2	57	1.79507111426e-05	0.00025739041794087665	IL2RB,IL2RA
506	Thyroid Diseases	C0040128	4	376	1.80011830248e-05	0.0002579001019367992	NRAS,IL2RA,IL2RG,IL5
507	Hepatitis	C0019159	4	377	1.823232218e-05	0.00025840978593272176	SOS1,IL2,IL2RA,IL5
508	IgA nephropathy, susceptibility to, 3	C0017661	5	650	1.82659360615e-05	0.00025891946992864426	JAK3,NRAS,IL2,IL5,IL5RA
509	Dengue Fever	C0011311	3	179	1.84381307373e-05	0.00025942915392456676	IL2RA,IL3RA,CSF2
510	Fetal ultrasound soft marker	C4023366	2	58	1.89187161735e-05	0.00025993883792048926	SOS1,NRAS
511	Neoplasms, Experimental	C0027659	2	58	1.89187161735e-05	0.0002604485219164118	NRAS,IL2
512	Cowden syndrome 1	C0018553	2	59	1.99205682567e-05	0.0002609582059123344	STAT5B,STAT5A
513	Abnormality of bone marrow cell morphology	C4021634	3	183	2.01093292926e-05	0.0002614678899082569	NRAS,IL2RA,IL2RG
514	Sarcoidosis, Pulmonary	C0036205	2	60	2.09566945191e-05	0.00026197757390417943	IL2,CSF2
515	Adverse drug events and drug allergies	C0041755	2	60	2.09566945191e-05	0.00026248725790010193	CSF2,IL3
516	Lymphoma, Follicular	C0024301	4	389	2.11918645583e-05	0.0002629969418960245	IL2RA,IL5,STAT5B,STAT5A
517	Hypersensitivity	C0020517	3	186	2.14340016431e-05	0.00026350662589194704	IL2RB,IL2,IL5RA
532	Bronchiolitis Obliterans	C0006272	2	61	2.202778507e-05	0.00027115188583078494	IL2,CSF2
533	Memory Loss	C0002622	2	61	2.202778507e-05	0.00027166156982670744	IL2,CSF2
534	Misalignment of teeth	C1852504	3	188	2.23519969439e-05	0.00027217125382263	SOS1,IL2RB,IL2RA
535	Abnormal hair quantity	C4023397	4	395	2.28055486258e-05	0.0002726809378185525	SOS1,NRAS,IL2RA,IL2RG
536	Childhood Leukemia	C1332977	2	62	2.31342807985e-05	0.000273190621814475	NRAS,CSF2
537	Arthritis, Rheumatoid	C0003864	6	1030	2.32514572163e-05	0.00027370030581039755	IL2RB,NRAS,IL2,IL2RA,CSF2,IL3
538	Juvenile rheumatoid arthritis	C3714757	3	190	2.32986492256e-05	0.0002742099898063201	IL2RB,IL2,IL2RA
539	Colitis, Ulcerative	C0009319	5	679	2.33633973559e-05	0.0002747196738022426	JAK3,IL2,IL2RA,STAT5B,CSF2
540	Alopecia	C0002170	3	191	2.37828759261e-05	0.00027522935779816516	NRAS,IL2RA,IL2RG
541	secondary acute myeloid leukemia	C0280449	2	63	2.42767485685e-05	0.00027573904179408766	INPP5D,IL3
542	Helminthiasis	C0018889	2	63	2.42767485685e-05	0.0002762487257900102	IL2,IL5
543	Diamond-Blackfan anemia	C1260899	2	63	2.42767485685e-05	0.0002767584097859328	CSF2,IL3
544	Webbed neck	C0221217	2	63	2.42767485685e-05	0.0002772680937818552	SOS1,NRAS
545	Low posterior hairline	C1855728	2	64	2.54557643099e-05	0.0002777777777777778	SOS1,NRAS
546	gliosarcoma	C0206726	2	64	2.54557643099e-05	0.0002782874617737003	SOS1,IL2
547	Abnormality of the posterior hairline	C4022607	2	64	2.54557643099e-05	0.00027879714576962283	SOS1,NRAS
548	Trachoma	C0040592	2	64	2.54557643099e-05	0.0002793068297655454	IL5RA,CSF2
549	Abnormal leukocyte count	C0152009	4	406	2.60116199581e-05	0.0002798165137614679	JAK3,NRAS,IL2RA,IL2RG
550	Abnormality of cellular immune system	C4023612	4	406	2.60116199581e-05	0.00028032619775739045	JAK3,NRAS,IL2RA,IL2RG
551	Progressive supranuclear ophthalmoplegia	C0038868	2	65	2.66718399164e-05	0.00028083588175331295	IL2,CSF2
552	Proportionate short stature	C0205351	2	65	2.66718399164e-05	0.0002813455657492355	INPPL1,STAT5B
553	Lipoma	C0023798	2	65	2.66718399164e-05	0.000281855249745158	STAT5B,STAT5A
554	Chronic hepatitis	C0019189	3	197	2.6845172416e-05	0.0002823649337410805	IL2,IL5,SHC1
567	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	8	1967	2.77354874233e-05	0.0002889908256880734	SOS1,NRAS,IL2,IL2RA,JAK1,IL2RG,STAT5B,CSF2
568	Arteriosclerosis	C0003850	6	1059	2.77989242267e-05	0.00028950050968399595	SOS1,IL2,IL2RA,IL5,CSF2,INPP5D
569	Noonan syndrome 1	C0028326	2	66	2.79255713382e-05	0.00029001019367991845	SOS1,NRAS
570	Pulmonic stenosis	C0034089	2	68	3.05481178537e-05	0.000290519877675841	SOS1,NRAS
571	Primary immune deficiency disorder	C0398686	2	68	3.05481178537e-05	0.0002910295616717635	JAK3,IL2RG
572	Non-small cell lung carcinoma	C0007131	8	1993	3.0800607725e-05	0.000291539245667686	SOS1,NRAS,IL2,IL2RA,JAK1,STAT5B,STAT5A,CSF2
573	Colorectal cancer 1	C0009402	9	2543	3.10852002614e-05	0.00029204892966360857	GRB2,INPPL1,SOS1,IL2RB,NRAS,IL2,STAT5B,STAT5A,CSF2
574	Abnormality of joint mobility	C4023216	5	715	3.12321818312e-05	0.00029255861365953107	INPPL1,SOS1,IL2RB,NRAS,IL2RA
575	Glioma	C0017638	8	1997	3.12970074819e-05	0.0002930682976554536	GRB2,SOS1,IL2RB,IL2,IL2RA,STAT5B,CSF2,IL3
576	Abnormal intermamillary distance	C4022412	2	69	3.19178957657e-05	0.0002935779816513762	SOS1,NRAS
577	Wide intermamillary distance	C1827524	2	69	3.19178957657e-05	0.0002940876656472987	SOS1,NRAS
578	Abnormality of cells of the lymphoid lineage	C4023027	2	69	3.19178957657e-05	0.00029459734964322123	IL2RA,IL2RG
579	Intraocular melanoma	C0220633	3	206	3.19690385032e-05	0.00029510703363914374	NRAS,IL2,CSF2
580	Skin lesion	C0037284	2	70	3.33275336974e-05	0.00029561671763506624	NRAS,IL2
581	Bronchitis	C0006277	2	70	3.33275336974e-05	0.0002961264016309888	IL2RG,CSF2
582	Myasthenia Gravis	C0026896	3	209	3.38263100104e-05	0.0002966360856269113	IL2RB,IL2,IL2RA
583	Cancer of Head and Neck	C0278996	4	430	3.42239170675e-05	0.00029714576962283385	IL2,STAT5B,STAT5A,CSF2
584	Endometriosis	C0014175	5	727	3.42854297197e-05	0.0002976554536187564	SOS1,IL2RB,JAK1,SHC1,CSF2
585	Abnormality of the liver	C4021780	5	727	3.42854297197e-05	0.0002981651376146789	INPPL1,SOS1,NRAS,IL2RA,IL2RG
608	 {HIV-1 viremia, susceptibility to}, 609423 (3)	C0042749	2	71	3.47774868757e-05	0.000309887869520897	IL2,JAK1
609	Retroviridae Infections	C0035369	2	71	3.47774868757e-05	0.0003103975535168196	IL2RA,CSF2
610	Abnormality of the pulmonary artery	C0009681	2	72	3.62683231956e-05	0.0003109072375127421	SOS1,NRAS
611	Pathologic Neovascularization	C0027686	2	74	3.93746406144e-05	0.00031141692150866464	JAK3,CSF2
612	Breast Cancer Model	C1511291	2	74	3.93746406144e-05	0.0003119266055045872	GRB2,IL2
613	Eating disorder	C0013473	2	75	4.09912609484e-05	0.0003124362895005097	IL2RB,CSF2
614	Pleural Effusion, Malignant	C0080032	2	75	4.09912609484e-05	0.00031294597349643225	IL2,IL2RA
615	Blast Phase	C0005699	3	221	4.20555001261e-05	0.00031345565749235475	NRAS,IL2,CSF2
632	Abnormality of digestive system physiology	C4293692	6	1132	4.25994421011e-05	0.0003221202854230377	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG
633	Abnormal shape of the occiput	C4023459	2	76	4.26507960374e-05	0.00032262996941896026	INPPL1,NRAS
634	Papillary thyroid carcinoma	C0238463	4	451	4.29497704124e-05	0.00032313965341488276	SOS1,NRAS,IL2,IL2RA
635	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	C3469521	3	223	4.35575729124e-05	0.0003236493374108053	JAK1,CSF2,IL3
636	Other disorders of the nervous system	C0027765	4	454	4.43253814253e-05	0.0003241590214067278	IL2RB,IL2,IL2RA,CSF2
637	Triangular face	C1835884	2	77	4.43539436945e-05	0.00032466870540265037	SOS1,NRAS
638	Multiple Sclerosis	C0026769	6	1140	4.45566903374e-05	0.0003251783893985729	IL2RB,IL2,IL2RA,JAK1,IL5RA,CSF2
639	pediatric acute myeloblastic leukemia	C0220621	2	78	4.61011066288e-05	0.0003256880733944954	NRAS,IL2RG
640	Triple Negative Breast Neoplasms	C3539878	4	461	4.76681716005e-05	0.000326197757390418	IL2RB,IL2,JAK1,IL2RG
641	Alopecia Areata	C0002171	2	79	4.78927891242e-05	0.00032670744138634043	IL2,IL2RA
642	Leukemia, Myeloid, Chronic-Phase	C0023474	2	79	4.78927891242e-05	0.000327217125382263	NRAS,IL3
643	Virus Diseases	C0042769	5	772	4.79537026833e-05	0.00032772680937818554	IL2,IL2RA,IL5,CSF2,INPP5D
644	Lung Neoplasms	C0024121	6	1155	4.84270270457e-05	0.00032823649337410804	NRAS,IL2,JAK1,STAT5B,STAT5A,CSF2
645	Colorectal cancer	C1527249	9	2681	4.92406281006e-05	0.0003287461773700306	GRB2,INPPL1,SOS1,IL2RB,NRAS,IL2,STAT5B,STAT5A,CSF2
646	Abnormality of metabolism/homeostasis	C4021768	7	1607	4.95383320886e-05	0.0003292558613659531	JAK3,INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
647	Duodenal Ulcer	C0013295	2	80	4.97295913541e-05	0.00032976554536187565	IL2,IL2RA
663	Multiple Endocrine Neoplasia Type 1	C0025267	2	81	5.16120089308e-05	0.0003379204892966361	NRAS,CSF2
664	Hormone refractory prostate cancer	C1328504	2	81	5.16120089308e-05	0.0003384301732925586	IL2,CSF2
665	Delayed skeletal maturation	C0541764	3	234	5.25315728382e-05	0.00033893985728848116	INPPL1,SOS1,NRAS
666	Tetanus	C0039614	2	82	5.35405950057e-05	0.0003394495412844037	IL2,IL5
667	Abnormality of the helix	C1856660	2	82	5.35405950057e-05	0.0003399592252803262	SOS1,NRAS
668	Stromal Neoplasm	C0879615	2	82	5.35405950057e-05	0.0003404689092762487	SOS1,IL2RG
669	Malignant neoplasm of pancreas	C0346647	7	1625	5.36366482063e-05	0.0003409785932721712	SOS1,NRAS,IL2,IL2RA,JAK1,STAT5B,CSF2
670	Abnormality of the rib cage	C4025763	3	237	5.51972739119e-05	0.0003414882772680938	INPPL1,SOS1,NRAS
671	Lichen Planus, Oral	C0206139	2	83	5.55158890591e-05	0.00034199796126401633	IL2,IL5
672	Mitral stenosis	C0026269	3	238	5.61074483372e-05	0.00034250764525993883	IL2,IL2RA,CSF2
673	Prostate carcinoma	C0600139	9	2734	5.83274880468e-05	0.0003430173292558614	SOS1,IL2,IL2RA,JAK1,IL5,SHC1,STAT5B,STAT5A,CSF2
674	Vitiligo	C0042900	3	241	5.89038184065e-05	0.00034352701325178394	IL2,IL2RA,CSF2
675	Dermatosis NOS	C0037274	4	483	5.94633122226e-05	0.00034403669724770644	IL2RB,IL2,IL2RA,IL5
693	Pectus carinatum	C0158731	2	86	6.17267774552e-05	0.00035321100917431195	SOS1,NRAS
694	Anemia due to reduced life span of red cells	C4021112	2	86	6.17267774552e-05	0.00035372069317023445	NRAS,IL2RA
695	Limitation of joint mobility	C1857108	3	244	6.18006703876e-05	0.00035423037716615695	INPPL1,IL2RB,IL2RA
696	Major depressive disorder	C1269683	4	489	6.30419464464e-05	0.0003547400611620795	IL2RB,IL2,IL2RA,CSF2RB
697	Herpes NOS	C0019340	2	87	6.38938803493e-05	0.00035524974515800206	IL2RA,CSF2
698	Bipolar affective disorder	C0005586	5	817	6.57048791004e-05	0.00035575942915392456	SOS1,IL2RB,NRAS,IL2RA,CSF2RB
699	Recurrent upper respiratory tract infections	C0581381	2	88	6.6110236859e-05	0.0003562691131498471	JAK3,IL2RG
700	Abnormality of the sternum	C1860493	3	249	6.68583302224e-05	0.0003567787971457696	INPPL1,SOS1,NRAS
701	Fanconi anemia	C0015625	3	249	6.68583302224e-05	0.0003572884811416922	JAK1,CSF2,IL3
702	Brachydactyly, type a1, d	C0221357	3	250	6.79050827165e-05	0.00035779816513761473	INPPL1,SOS1,NRAS
703	Influenza	C0021400	4	497	6.80704473786e-05	0.0003583078491335372	NRAS,IL2,IL5,IL3
704	Plasmacytoma	C0032131	2	89	6.83763012304e-05	0.00035881753312945973	IL2,IL3
722	Latent autoimmune diabetes mellitus in adult	C0205734	2	90	7.06926701465e-05	0.00036799184505606524	IL2,IL2RA
723	Thick lower lip vermilion	C1839739	2	90	7.06926701465e-05	0.00036850152905198774	SOS1,NRAS
724	Thyroid associated opthalmopathies	C0339143	2	90	7.06926701465e-05	0.0003690112130479103	IL2,IL5
725	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	7	1700	7.3920901303e-05	0.00036952089704383285	SOS1,NRAS,IL2,IL5,STAT5B,STAT5A,CSF2
726	Ulcerative colitis	C0009324	5	837	7.51233839287e-05	0.00037003058103975535	IL2,IL2RA,IL5,STAT5A,IL3
727	Lung cancer	C0684249	8	2234	7.59642623512e-05	0.0003705402650356779	SOS1,NRAS,IL2,IL2RA,JAK1,SHC1,STAT5B,CSF2
728	Abnormality of the abdominal organs	C4021764	5	842	7.76394321809e-05	0.00037104994903160046	INPPL1,SOS1,NRAS,IL2RA,IL2RG
729	airway disease	C0699949	2	94	8.04712443047e-05	0.00037155963302752296	IL2RB,IL5
730	Follicular adenoma	C0205647	2	94	8.04712443047e-05	0.00037206931702344546	SOS1,NRAS
740	Increased head circumference	C4083076	3	263	8.26277267993e-05	0.00037716615698267075	INPPL1,SOS1,NRAS
741	Prolactinoma, familial	C0033375	2	95	8.30465915108e-05	0.00037767584097859325	STAT5B,STAT5A
742	Abnormality of the pulmonary valve	C3164374	2	95	8.30465915108e-05	0.0003781855249745158	SOS1,NRAS
743	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	3	265	8.50834456471e-05	0.00037869520897043836	IL2,CSF2,IL3
744	Glomerulonephritis, Membranous	C0017658	3	267	8.7591950964e-05	0.00037920489296636086	SOS1,IL2,IL2RA
745	Abnormal urinary electrolyte concentration	C4022833	2	97	8.83579214029e-05	0.0003797145769622834	INPPL1,NRAS
746	Atherosclerosis	C0004153	6	1271	8.87834255111e-05	0.00038022426095820597	SOS1,IL2,IL2RA,IL5,CSF2,INPP5D
747	Abnormality of skeletal maturation	C4025818	3	268	8.88661425569e-05	0.0003807339449541284	INPPL1,SOS1,NRAS
748	Synostosis involving bones of the feet	C0039093	2	98	9.10948115305e-05	0.00038124362895005097	SOS1,NRAS
749	Autism 15	C0004352	5	868	9.18358578182e-05	0.00038175331294597347	SOS1,NRAS,IL2,IL5,CSF2
758	Advanced cancer	C0877373	2	100	9.67335404746e-05	0.00038634046890927625	IL2,CSF2
759	Psoriasis	C0033860	5	878	9.78198504576e-05	0.00038685015290519875	IL2,IL2RA,JAK1,CSF2,IL3
760	Abnormality of the endocrine system	C4025823	5	878	9.78198504576e-05	0.0003873598369011213	SOS1,NRAS,IL2RA,IL2RG,STAT5B
761	Congenital chromosomal disease	C0008626	4	537	9.80475613157e-05	0.00038786952089704386	NRAS,IL2,CSF2,IL3
762	Primary adrenal insufficiency	C0001403	2	102	0.00010259558288	0.00038837920489296637	IL2,IL2RA
763	Melanoma, B16	C0004565	2	102	0.00010259558288	0.0003888888888888889	IL2,CSF2
764	Abnormality of the nasopharynx	C4025750	2	102	0.00010259558288	0.0003893985728848114	JAK3,IL2RG
765	Medulloblastoma	C0025149	4	543	0.000103303250439	0.0003899082568807339	GRB2,SOS1,IL2RB,CSF2
766	Inflammatory disorder	C1290884	3	279	0.000103790573103	0.0003904179408766565	IL2,IL5,CSF2
767	Esophageal Squamous Cell Carcinoma	C0279626	5	888	0.00010411213941	0.000390927624872579	GRB2,SOS1,IL2RB,IL2RA,IL5
777	Malignant tumor of cervix	C0007847	5	889	0.000104758776362	0.00039602446483180426	JAK3,SOS1,IL2,STAT5B,STAT5A
778	Macrocephaly, dysmorphic facies, and psychomotor retardation	C0221355	3	281	0.000106688177879	0.0003965341488277268	INPPL1,SOS1,NRAS
779	Adult Acute Lymphocytic Leukemia	C0751606	2	104	0.000108684886587	0.00039704383282364937	IL2RA,JAK1
780	Malignant tumor of prostate	C0376358	9	2940	0.000108779955164	0.0003975535168195719	SOS1,NRAS,IL2,IL2RA,JAK1,SHC1,STAT5B,STAT5A,CSF2
781	Xenograft Model	C1520166	4	551	0.000110645940964	0.00039806320081549443	IL2,IL2RA,JAK1,IL3RA
782	polyps	C0032584	3	284	0.000111144489766	0.00039857288481141693	NRAS,IL5,CSF2
783	Hereditary factor VIII deficiency disease	C0019069	2	105	0.000111816027751	0.00039908256880733943	IL2,IL2RA
784	Abnormality of T cell count	C1704258	5	903	0.000114154064817	0.000399592252803262	INPPL1,SOS1,NRAS,IL2RG,CSF2
785	Abnormality of skin physiology	C4023527	3	286	0.000114189528542	0.0004001019367991845	NRAS,IL2RA,IL2RG
786	Posttraumatic stress disorder	C0038436	2	106	0.000115005424618	0.00040061162079510704	IL2,STAT5B
798	Abnormality of the face	C4025871	7	1817	0.000118208846318	0.0004067278287461774	JAK3,INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
799	Abnormality of thyroid morphology	C4023195	2	107	0.000118253616039	0.00040723751274209994	NRAS,IL2RG
800	Apraxia	C0003635	2	108	0.000121561137966	0.0004077471967380224	IL2RB,IL2RA
801	Teratoma	C0039538	2	108	0.000121561137966	0.00040825688073394494	CSF2,IL3
802	Abnormal joint morphology	C0240083	5	915	0.000122732745334	0.0004087665647298675	INPPL1,SOS1,IL2RB,NRAS,IL2RA
803	Primary sclerosing cholangitis	C0566602	2	109	0.00012492832186	0.00040927624872579	IL2,IL2RA
804	Helicobacter Infections	C0079487	2	110	0.000128355831708	0.00040978593272171255	IL2,IL5
817	Myocarditis	C0027059	2	112	0.000135393452284	0.00041641182466870544	SOS1,IL2RA
818	Aplasia/Hypoplasia of the eyebrow	C4021956	2	112	0.000135393452284	0.0004169215086646279	SOS1,IL2RG
819	Squamous cell carcinoma	C0007137	7	1855	0.000136660158563	0.00041743119266055045	SOS1,NRAS,IL2,IL2RA,IL5,STAT5A,CSF2
820	Abnormality of dental morphology	C0040427	4	578	0.000138437059399	0.000417940876656473	SOS1,IL2RB,NRAS,IL2RA
821	Abnormality of coagulation	C1846821	2	113	0.000139004600374	0.0004184505606523955	SOS1,NRAS
822	CNS disorder	C0007682	2	113	0.000139004600374	0.00041896024464831806	CSF2,IL3
823	Increased inflammatory response	C4022803	4	581	0.000141828045545	0.0004194699286442406	JAK3,IL2RB,IL2RA,IL2RG
824	Abnormal inflammatory response	C4022805	4	581	0.000141828045545	0.0004199796126401631	JAK3,IL2RB,IL2RA,IL2RG
825	Autoimmune thyroid disease 3	C0178468	2	114	0.000142677863913	0.00042048929663608567	IL2RA,IL5
826	Multicystic renal dysplasia, bilateral	C1840451	2	114	0.000142677863913	0.00042099898063200817	IL3RA,IL3
827	Abnormality of skin adnexa morphology	C4023518	5	942	0.000143924072708	0.00042150866462793067	INPPL1,SOS1,NRAS,IL2RA,IL2RG
837	Abnormality of the intestine	C0021831	4	584	0.000145282567549	0.00042660550458715595	JAK3,NRAS,IL2RA,IL5
838	Abnormality of upper limb bone	C4022454	3	305	0.000146225319876	0.0004271151885830785	INPPL1,SOS1,NRAS
839	Reperfusion Injury	C0035126	3	305	0.000146225319876	0.000427624872579001	STAT5B,STAT5A,INPP5D
840	Abnormality of the hairline	C4024297	2	115	0.000146413833988	0.00042813455657492356	SOS1,NRAS
841	Meningitis	C0497299	2	116	0.000150212928356	0.0004286442405708461	JAK3,CSF2
842	Gastric ulcer	C0038358	2	116	0.000150212928356	0.0004291539245667686	SOS1,IL2
858	Abnormality of the ulna	C4025662	2	119	0.000161993841662	0.00043730886850152907	SOS1,NRAS
859	Sepsis	C0243026	4	602	0.000167390318217	0.0004378185524974516	IL2,IL2RA,IL2RG,CSF2
860	Leiomyoma	C0023267	3	316	0.000167504955325	0.00043832823649337413	GRB2,IL2,CSF2
861	Abnormality of the midface	C4021811	3	317	0.000169544659645	0.0004388379204892967	INPPL1,SOS1,NRAS
862	High forehead	C0239676	2	121	0.000170172244633	0.00043934760448521913	SOS1,NRAS
863	Thick vermilion border	C1836543	2	122	0.000174360239501	0.0004398572884811417	SOS1,NRAS
864	Peripheral T-Cell Lymphoma	C0079774	2	122	0.000174360239501	0.00044036697247706424	IL2RB,CSF2
865	Acute Coronary Syndrome	C0948089	3	320	0.000175771785939	0.00044087665647298674	IL2RA,STAT5B,STAT5A
871	Abnormality of hair texture	C4023722	2	124	0.000182935863337	0.0004439347604485219	SOS1,NRAS
872	Urticaria	C0042109	2	124	0.000182935863337	0.0004444444444444444	IL2RA,IL2RG
873	Abnormal nipple morphology	C3839073	2	124	0.000182935863337	0.00044495412844036697	SOS1,NRAS
874	Pancytopenia	C0030312	2	124	0.000182935863337	0.0004454638124362895	NRAS,CSF2
875	Diabetic Nephropathies	C0011881	4	616	0.000186302282003	0.000445973496432212	INPPL1,SOS1,STAT5B,STAT5A
885	Failure to thrive	C0015544	4	622	0.000194891362968	0.0004510703363914373	JAK3,IL2RG,STAT5B,CSF2
886	Periodontitis	C0031099	3	331	0.000200027635797	0.00045158002038735986	IL2,IL2RA,CSF2
887	Uterine leiomyoma	C0042133	3	331	0.000200027635797	0.0004520897043832824	GRB2,IL2,CSF2
888	Pain	C0030193	4	628	0.000203780911412	0.0004525993883792049	IL2RB,IL2,IL2RA,CSF2
889	Head and Neck Neoplasms	C0018671	3	333	0.000204684705192	0.0004531090723751274	IL2RA,STAT5B,STAT5A
890	Abnormality of the pharynx	C4025838	2	130	0.000210295367126	0.0004536187563710499	JAK3,IL2RG
901	Small cell lung cancer	C0149925	4	638	0.000219283882232	0.00045922528032619776	SOS1,IL2,IL2RA,CSF2
902	Gingival Diseases	C0017563	2	132	0.00021997159102	0.0004597349643221203	IL2,IL2RA
903	Intraepithelial Neoplasia	C0878500	2	132	0.00021997159102	0.0004602446483180428	STAT5B,STAT5A
904	Abnormality of the pulmonary vasculature	C4025271	2	133	0.000224916101667	0.00046075433231396537	SOS1,NRAS
905	Metastatic malignant neoplasm to brain	C0220650	2	133	0.000224916101667	0.0004612640163098879	NRAS,CSF2
906	Abnormality of the head	C4021812	7	1995	0.00022669509804	0.00046177370030581037	JAK3,INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
907	Rheumatoid Nodule	C0035450	1	25	0.000228689163915	0.0004622833843017329	IL2
908	Deep philtrum	C1839797	1	25	0.000228689163915	0.0004627930682976554	NRAS
909	Post-transplant lymphoproliferative disorder	C0432487	1	25	0.000228689163915	0.000463302752293578	NRAS
910	Latent Tuberculosis	C1609538	1	25	0.000228689163915	0.00046381243628950054	IL2RA
911	Pleural Tuberculosis	C0041326	1	25	0.000228689163915	0.00046432212028542304	IL2RA
912	Chronic berylliosis	C0221052	1	25	0.000228689163915	0.0004648318042813456	IL2
913	Leg Ulcer	C0023223	1	25	0.000228689163915	0.0004653414882772681	SOS1
914	Flushing	C0016382	1	25	0.000228689163915	0.00046585117227319065	CSF2
915	Blue irides	C0578626	1	25	0.000228689163915	0.00046636085626911315	SOS1
916	Thyroiditis	C0040147	2	134	0.00022993226528	0.00046687054026503565	IL2RA,IL2RG
917	Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis	C1853242	2	134	0.00022993226528	0.0004673802242609582	SOS1,NRAS
918	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	2	134	0.00022993226528	0.00046788990825688076	IL2,CSF2
919	Congenital abnormal hair pattern	C4023398	2	134	0.00022993226528	0.00046839959225280326	SOS1,NRAS
920	Abnormality of the nose	C0265736	5	1028	0.000231551850906	0.0004689092762487258	JAK3,INPPL1,SOS1,NRAS,IL2RG
921	Anaplastic Oligodendroglioma	C0334590	2	135	0.000235020347383	0.0004694189602446483	IL2RB,IL2
922	Myositis	C0027121	2	136	0.000240180864452	0.0004699286442405709	IL5,CSF2
923	Motor Neuron Disease	C0085084	2	136	0.000240180864452	0.00047043832823649343	SOS1,CSF2
924	Sjogren's Syndrome	C1527336	2	137	0.000245414355893	0.0004709480122324159	IL2,IL2RA
925	Sarcoma, Epithelioid	C0205944	1	26	0.000247611236573	0.00047145769622833843	IL2
926	Hemorrhagic Fever with Renal Syndrome	C0019101	1	26	0.000247611236573	0.00047196738022426093	IL2RA
927	Acute-Phase Reaction	C0001349	1	26	0.000247611236573	0.0004724770642201835	STAT5B
928	Granulocytic Sarcoma	C0152276	1	26	0.000247611236573	0.00047298674821610604	IL2RA
929	Hypoplasia of the thymus	C0685891	1	26	0.000247611236573	0.00047349643221202854	IL2RG
930	Congenital short bowel syndrome	C0021847	1	26	0.000247611236573	0.0004740061162079511	SOS1
931	Papillary adenocarcinoma	C0001420	1	26	0.000247611236573	0.0004745158002038736	NRAS
932	Peritoneal Mesothelioma	C0346109	1	26	0.000247611236573	0.00047502548419979616	JAK3
933	Non-medullary thyroid carcinoma	C3501843	1	26	0.000247611236573	0.00047553516819571866	NRAS
934	Acute hepatitis	C0267797	1	26	0.000247611236573	0.00047604485219164116	SOS1
935	Narcolepsy-Cataplexy Syndrome	C0751362	1	26	0.000247611236573	0.0004765545361875637	CSF2
936	Abnormality of head or neck	C0854297	7	2021	0.000247902568143	0.00047706422018348627	JAK3,INPPL1,SOS1,IL2RB,NRAS,IL2RA,IL2RG
937	Pruritus	C0033774	2	138	0.000250721200439	0.00047757390417940877	NRAS,IL2RG
938	Synostosis of joints	C4022183	2	138	0.000250721200439	0.0004780835881753313	SOS1,NRAS
939	Lung Diseases, Interstitial	C0206062	2	138	0.000250721200439	0.0004785932721712538	CSF2RA,IL2
940	Carcinoma of cervix	C0302592	5	1045	0.000253042163332	0.0004791029561671764	JAK3,SOS1,IL2,STAT5B,STAT5A
941	Lyme Disease	C0024198	2	140	0.000261556736634	0.00047961264016309894	SHC1,CSF2
942	Seborrheic keratosis	C0022603	1	27	0.000267274002437	0.0004801223241590214	NRAS
943	Syphilis	C0039128	1	27	0.000267274002437	0.00048063200815494394	CSF2
944	Tuberculosis, Meningeal	C0041318	1	27	0.000267274002437	0.00048114169215086644	CSF2
945	Steroid-sensitive nephrotic syndrome	C0403396	1	27	0.000267274002437	0.000481651376146789	IL2
946	Aplasia/Hypoplasia of the thymus	C4023796	1	27	0.000267274002437	0.00048216106014271155	IL2RG
947	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	C0237849	1	27	0.000267274002437	0.00048267074413863405	IL2RG
948	Invasive Skin Melanoma	C1708565	1	27	0.000267274002437	0.0004831804281345566	NRAS
949	Mycosis Fungoides	C0026948	2	143	0.000278371455565	0.0004836901121304791	IL2,IL5
950	Chronic liver disease	C0341439	2	144	0.000284127912485	0.00048419979612640166	SOS1,IL2
951	Monoclonal Gammopathy of Undetermined Significance	C0026470	2	144	0.000284127912485	0.00048470948012232416	NRAS,IL2RA
952	Renal neoplasm	C0022665	3	363	0.000284334325678	0.00048521916411824667	NRAS,IL2,CSF2
953	Periodontal Attachment Loss	C0206114	1	28	0.000287676288521	0.0004857288481141692	IL2
954	Papillon-Lefevre Disease	C0030360	1	28	0.000287676288521	0.0004862385321100918	IL2
955	Otitis Media with Effusion	C0029883	1	28	0.000287676288521	0.0004867482161060143	IL5
956	Chronic mucocutaneous candidiasis	C0006845	1	28	0.000287676288521	0.00048725790010193683	IL2RG
957	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	1	28	0.000287676288521	0.00048776758409785933	IL2
958	Tick-Borne Encephalitis	C0014061	1	28	0.000287676288521	0.0004882772680937819	IL2
959	Acquired CJD	C2931859	1	28	0.000287676288521	0.0004887869520897044	CSF2
960	Bovine Anaplasmosis	C0002797	1	28	0.000287676288521	0.0004892966360856269	IL2
961	Neoplasm of the central nervous system	C0085136	2	145	0.00028996075169	0.0004898063200815494	SOS1,NRAS
962	Joint hyperflexibility	C3553764	2	148	0.000307922892976	0.000490316004077472	SOS1,NRAS
963	Abnormal hair pattern	C4023721	2	148	0.000307922892976	0.0004908256880733946	SOS1,NRAS
964	Abnormality of the pubic bone	C4021738	1	29	0.000308816861592	0.0004913353720693171	INPPL1
965	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	C1292772	1	29	0.000308816861592	0.0004918450560652396	CSF2
966	Autoimmune thrombocytopenia	C0242584	1	29	0.000308816861592	0.0004923547400611621	NRAS
967	Pyruvate carboxylase deficiency	C0034341	1	29	0.000308816861592	0.0004928644240570846	NRAS
968	Recurrent viral infections	C1837066	1	29	0.000308816861592	0.0004933741080530072	IL2RA
969	Hypogammaglobulinemia	C0086438	1	29	0.000308816861592	0.0004938837920489297	CSF2
970	Arthralgia	C0003862	2	149	0.000314066179878	0.0004943934760448522	IL2RB,IL2RA
971	Abnormality of erythrocytes	C0391870	3	374	0.000318461707553	0.0004949031600407748	NRAS,IL2RA,IL2RG
972	Abnormality of the radius	C4025675	2	151	0.000326589178061	0.0004954128440366973	SOS1,NRAS
973	Hereditary pancreatitis	C0238339	3	377	0.000328258594943	0.0004959225280326198	SOS1,IL2RB,IL2RA
974	Abnormal QRS complex	C0205161	5	1098	0.0003303713991	0.0004964322120285423	INPPL1,SOS1,NRAS,IL2RA,IL2RG
975	Familial cold-induced inflammatory syndrome 1, 120100 (3)	C0009443	1	30	0.000330694409166	0.0004969418960244648	IL2
976	Cubitus valgus	C0158465	1	30	0.000330694409166	0.0004974515800203874	SOS1
977	Recurrent bronchitis	C0741796	1	30	0.000330694409166	0.0004979612640163099	IL2RG
978	pricking of skin	C0476227	1	30	0.000330694409166	0.0004984709480122324	IL2RA
979	Oral aphthae	C0038363	1	30	0.000330694409166	0.000498980632008155	IL2
980	Disorder of amino acid metabolism	C0002514	1	30	0.000330694409166	0.0004994903160040775	CSF2
981	Isolated somatotropin deficiency	C3714796	1	30	0.000330694409166	0.0005	STAT5B
982	Stomach cancer	C0699791	7	2109	0.000332280651888	0.0005005096839959225	JAK3,GRB2,SOS1,IL2RB,NRAS,IL2,JAK1
983	Diarrhea 8, secretory sodium, congenital	C0011991	3	379	0.000334909215072	0.0005010193679918451	JAK3,IL2RA,IL2RG
984	Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	C0002878	2	153	0.000339430537076	0.0005015290519877675	NRAS,IL2RA
985	Growth abnormality	C0262361	6	1578	0.00034028357439	0.0005020387359836901	JAK3,INPPL1,SOS1,NRAS,IL2RG,STAT5B
986	Thalassemia	C0039730	2	154	0.000345971572208	0.0005025484199796126	IL2RA,IL3
987	Abnormality of the oral cavity	C4025887	5	1109	0.000348539480835	0.0005030581039755352	INPPL1,SOS1,IL2RB,NRAS,IL2RA
988	Abnormality of the neck	C0266623	3	384	0.000351959092289	0.0005035677879714577	INPPL1,SOS1,NRAS
989	Inflammatory abnormality of the eye	C4020969	2	155	0.000352593578456	0.0005040774719673802	IL2RB,IL2RA
990	Hypophosphatemic rickets	C3536983	1	31	0.000353307843291	0.0005045871559633027	NRAS
991	Distal myopathy Markesbery-Griggs type	C1838244	1	31	0.000353307843291	0.0005050968399592252	JAK3
992	Monocytosis	C0085702	1	31	0.000353307843291	0.0005056065239551478	NRAS
993	Hypersomnia	C0917799	1	31	0.000353307843291	0.0005061162079510703	CSF2
994	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	0.000353307843291	0.0005066258919469928	CSF2
995	Abnormality of eosinophils	C4025738	1	31	0.000353307843291	0.0005071355759429154	IL2RG
996	Herpes simplex encephalitis, susceptibility to, 7	C0276226	1	31	0.000353307843291	0.000507645259938838	CSF2
997	Myasthenic syndrome, congenital, 8	C0022972	1	31	0.000353307843291	0.0005081549439347605	IL2RA
998	HYPER-IgM IMMUNODEFICIENCY, X-LINKED, WITH ECTODERMAL DYSPLASIA, HYPOHIDROTIC	C0398689	1	31	0.000353307843291	0.0005086646279306831	IL2RA
999	Malignant melanoma of eye	C0558356	1	31	0.000353307843291	0.0005091743119266055	NRAS
1000	Insulinoma	C0021670	2	157	0.000366081657683	0.000509683995922528	STAT5B,STAT5A
1001	Abnormal dermatoglyphics	C0432333	2	157	0.000366081657683	0.0005101936799184506	SOS1,NRAS
1002	Abnormality of facial skeleton	C2315229	4	715	0.000370988975413	0.0005107033639143731	INPPL1,SOS1,NRAS,IL2RG
1003	3 beta-Hydroxysteroid dehydrogenase deficiency	C1291311	1	32	0.000376655826314	0.0005112130479102957	CSF2
1004	Niemann-Pick disease, type C	C0220756	1	32	0.000376655826314	0.0005117227319062182	CSF2
1005	Interstitial lung and liver disease	C0206061	1	32	0.000376655826314	0.0005122324159021407	IL2RA
1006	Pleomorphic adenoma of salivary gland	C1519176	1	32	0.000376655826314	0.0005127420998980632	IL2RA
1007	Familial Alzheimer Disease (FAD)	C0276496	1	32	0.000376655826314	0.0005132517838939858	CSF2
1008	Respiratory Hypersensitivity	C0035228	1	32	0.000376655826314	0.0005137614678899083	IL2
1009	TNF receptor-associated periodic fever syndrome (TRAPS)	C3889979	1	32	0.000376655826314	0.0005142711518858308	IL2RB
1010	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	3	393	0.00038420784171	0.0005147808358817533	IL2,IL2RA,IL5
1011	VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	C1847835	2	160	0.000386931111601	0.0005152905198776758	IL2,CSF2
1012	Abnormality of lower lip	C4025883	2	160	0.000386931111601	0.0005158002038735984	SOS1,NRAS
1013	Oestrogen deficiency	C0853662	1	33	0.000400737242045	0.0005163098878695209	IL2RG
1014	Prostate Cancer, Hereditary, 7	C1853195	1	33	0.000400737242045	0.0005168195718654435	SOS1
1015	Periodontal Pocket	C0031094	1	33	0.000400737242045	0.0005173292558613659	IL2
1016	Asymptomatic Infections	C0275522	1	33	0.000400737242045	0.0005178389398572885	CSF2
1017	Stage IV Ovarian Carcinoma	C0278688	1	33	0.000400737242045	0.000518348623853211	CSF2
1018	Flat occiput	C1837402	1	33	0.000400737242045	0.0005188583078491335	INPPL1
1019	Normal pressure hydrocephalus	C0020258	1	33	0.000400737242045	0.0005193679918450561	CSF2
1020	Abnormality of cells of the monocyte/macrophage lineage	C4023025	1	33	0.000400737242045	0.0005198776758409785	NRAS
1021	IgG deficiency	C0162539	1	33	0.000400737242045	0.0005203873598369011	IL2RG
1022	Porencephaly	C0151860	1	33	0.000400737242045	0.0005208970438328236	NRAS
1023	Follicular neoplasm	C0474808	1	33	0.000400737242045	0.0005214067278287462	NRAS
1024	Uterine leiomyosarcoma	C0280631	1	33	0.000400737242045	0.0005219164118246687	NRAS
1025	Irritable bowel syndrome with diarrhea	C0022104	2	162	0.000401247141476	0.0005224260958205913	IL2,IL2RA
1026	Acquired Immunodeficiency Syndrome	C0001175	2	163	0.000408531305284	0.0005229357798165138	IL2,IL5
1027	Abnormality of forearm bone	C4022452	2	163	0.000408531305284	0.0005234454638124363	SOS1,NRAS
1028	Malignant neoplasm of kidney	C0740457	3	401	0.000414607847414	0.0005239551478083589	IL2,IL2RA,CSF2
1029	Abnormality of thyroid physiology	C0857576	2	164	0.000415900158309	0.0005244648318042814	IL2RA,IL2RG
1030	Abnormality of the forearm	C4025666	2	165	0.000423354178629	0.0005249745158002039	SOS1,NRAS
1031	Therapy-related myelodysplastic syndrome	C1292780	1	34	0.000425550702057	0.0005254841997961264	CSF2
1032	Erythrocytosis	C1527405	1	34	0.000425550702057	0.000525993883792049	JAK1
1033	Bisphosphonate-associated osteonecrosis	C2986536	1	34	0.000425550702057	0.0005265035677879715	NRAS
1034	Adenoviral infections	C0851887	1	34	0.000425550702057	0.0005270132517838941	CSF2
1035	Steroid-resistant nephrotic syndrome	C3266102	1	34	0.000425550702057	0.0005275229357798165	IL2
1036	Systemic aspergillosis	C0004030	1	34	0.000425550702057	0.000528032619775739	CSF2
1037	Meningitis, Pneumococcal	C0025295	1	34	0.000425550702057	0.0005285423037716616	CSF2
1038	Encephalomyelitis	C0014070	1	34	0.000425550702057	0.0005290519877675841	CSF2
1039	Prostate cancer recurrent	C0278838	1	34	0.000425550702057	0.0005295616717635067	CSF2
1040	Unipolar Depression	C0041696	3	406	0.000434461675286	0.0005300713557594292	IL2RB,IL2RA,CSF2RB
1041	Behcet Syndrome	C0004943	3	407	0.000438512713374	0.0005305810397553517	IL2,IL2RA,JAK1
1042	Vascular Diseases	C0042373	3	410	0.000450828225906	0.0005310907237512742	IL2,STAT5B,STAT5A
1043	Lupus Erythematosus, Cutaneous	C0024137	1	35	0.000451095233822	0.0005316004077471967	IL2RA
1044	Volvulus	C0042961	1	35	0.000451095233822	0.0005321100917431193	IL5
1045	Enterovirus Infections	C0014378	1	35	0.000451095233822	0.0005326197757390418	CSF2
1046	Antisocial Personality Disorder	C0003431	1	35	0.000451095233822	0.0005331294597349643	CSF2
1047	Asymmetric growth	C4022025	1	35	0.000451095233822	0.0005336391437308868	NRAS
1048	Enteritis	C0014335	1	35	0.000451095233822	0.0005341488277268094	STAT5B
1049	Rhinitis, Allergic, Perennial	C0035457	1	35	0.000451095233822	0.0005346585117227319	IL5
1050	Paranoid Schizophrenia	C0036349	1	35	0.000451095233822	0.0005351681957186545	IL2
1051	Equine Infectious Anemia	C0014661	1	35	0.000451095233822	0.0005356778797145769	IL2
1052	Proptosis	C0015300	2	171	0.000469888737598	0.0005361875637104994	SOS1,NRAS
1053	Amyotrophic lateral sclerosis type 1	C1862939	2	171	0.000469888737598	0.000536697247706422	JAK3,SHC1
1054	Brain Ischemia	C0007786	3	415	0.000471901998416	0.0005372069317023445	IL5RA,CSF2RB,CSF2
1055	Hepatic fibrosis	C0239946	3	416	0.000476199903613	0.0005377166156982672	SOS1,IL2RA,INPP5D
1056	Chronic schizophrenia	C0221765	1	36	0.000477369309531	0.0005382262996941895	IL2RG
1057	Metastatic Carcinoma	C1384494	1	36	0.000477369309531	0.0005387359836901122	IL2
1058	HTLV-I Infections	C0020097	1	36	0.000477369309531	0.0005392456676860347	IL2
1059	Microscopic Polyarteritis	C2347126	1	36	0.000477369309531	0.0005397553516819573	IL2
1060	Horseshoe kidney	C0221353	1	36	0.000477369309531	0.0005402650356778798	NRAS
1061	Polymyalgia Rheumatica	C0032533	1	36	0.000477369309531	0.0005407747196738022	IL2RA
1062	Prolonged bleeding time	C0439590	1	36	0.000477369309531	0.0005412844036697248	SOS1
1063	Malignant ascites	C0220656	1	36	0.000477369309531	0.0005417940876656473	IL2
1064	Abnormality of the periorbital region	C4025837	3	417	0.000480525732799	0.0005423037716615699	SOS1,NRAS,IL2RG
1065	Dissecting aneurysm of the thoracic aorta	C0729233	2	174	0.000494338724531	0.0005428134556574924	IL2,IL2RA
1066	Nevus	C0497388	2	174	0.000494338724531	0.0005433231396534149	SOS1,NRAS
1067	Cytomegalovirus Infections	C0010823	2	174	0.000494338724531	0.0005438328236493374	IL2,CSF2
1068	Abnormality of the digestive system	C0266015	6	1679	0.000496354608952	0.00054434250764526	JAK3,INPPL1,SOS1,NRAS,IL2RA,IL2RG
1069	Noonan syndrome with multiple lentigines	C0175704	1	37	0.000504371988931	0.0005448521916411825	SOS1
1070	Smallpox	C0037354	1	37	0.000504371988931	0.000545361875637105	CSF2
1071	Hyperphosphaturia	C0268079	1	37	0.000504371988931	0.0005458715596330275	NRAS
1072	Alveolar Bone Loss	C0002382	1	37	0.000504371988931	0.00054638124362895	IL2
1073	Autoimmune hemolytic anemia	C0002880	1	37	0.000504371988931	0.0005468909276248726	IL2RA
1074	Folic Acid Deficiency	C0016412	1	37	0.000504371988931	0.0005474006116207951	IL2
1075	Benign Prostatic Hyperplasia	C1704272	3	423	0.000507073605771	0.0005479102956167177	IL2,CSF2,IL3
1076	Abnormality of the hair	C0157733	4	766	0.000508450153081	0.0005484199796126402	SOS1,NRAS,IL2RA,IL2RG
1077	Pancreatic Carcinoma	C0235974	6	1690	0.000516360139168	0.0005489296636085627	SOS1,IL2,IL2RA,JAK1,STAT5B,CSF2
1078	Thyroid cancer, follicular	C0206682	2	177	0.000519591845612	0.0005494393476044852	SOS1,NRAS
1079	Abnormality of granulocytes	C0427515	2	178	0.000528189849839	0.0005499490316004077	NRAS,IL2RG
1080	Epiretinal membrane	C0339543	1	38	0.000532101885733	0.0005504587155963303	IL2RB
1081	Acute disease of cardiovascular system	C0001314	1	38	0.000532101885733	0.0005509683995922528	NRAS
1082	Chronic myelopathy	C0037928	1	38	0.000532101885733	0.0005514780835881753	IL2
1083	Ovarian hyperstimulation syndrome	C0085083	1	38	0.000532101885733	0.0005519877675840978	IL2
1084	Hypoplastic ilia	C1861218	1	38	0.000532101885733	0.0005524974515800204	INPPL1
1085	Personality disorder	C0031212	1	38	0.000532101885733	0.0005530071355759429	CSF2
1086	Alzheimer Disease	C0002395	6	1699	0.000533207770282	0.0005535168195718656	GRB2,IL2RB,IL2,CSF2,INPP5D,IL3
1087	Low-set, posteriorly rotated ears	C1857486	2	179	0.000536878901913	0.0005540265035677879	SOS1,NRAS
1088	Amyotrophy involving the shoulder musculature	C0026846	2	179	0.000536878901913	0.0005545361875637104	SOS1,STAT5A
1089	Trisomy	C0041107	2	179	0.000536878901913	0.000555045871559633	IL2RA,IL3
1090	Short nose	C1854114	2	180	0.00054565907485	0.0005555555555555556	INPPL1,NRAS
1091	Non-Malignant Ascites Adverse Event	C1559271	2	181	0.000554530987338	0.0005560652395514782	IL2,CSF2
